Paper11241272
Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection.
Scheiblhofer S and 8 others. Eur J Immunol, 2001. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection. Papers, record 11241272. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11241272
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Protozoan | Major topic |
| Antigens, Protozoan | Major topic |
| Glycosylphosphatidylinositols | Major topic |
| Malaria | Major topic |
| Protozoan Proteins | Major topic |
| Vaccines, DNA | Major topic |
| Animals | |
| Biolistics | |
| Female | |
| Immunoglobulin G | |
| Immunoglobulin Isotypes | |
| Mice | |
| Mice, Inbred BALB C | |
| Plasmodium berghei | |
| Protein Sorting Signals | |
| Sequence Deletion | |
| Th2 Cells | |
| Time Factors |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41253879 | mRNA delivery of circumsporozoite protein epitope-based malaria vaccines induces protection in a mouse model. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/41253879 | PubMed |
| 37827967 | Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences. | Vaccine | 2023 | https://conductscience.org/library/papers/37827967 | PubMed |
| 35729277 | Mapping immunogenic epitopes of an adhesin-like protein from Methanobrevibacter ruminantium M1 and comparison of empirical data with in silico prediction methods. | Sci Rep | 2022 | https://conductscience.org/library/papers/35729277 | PubMed |
| 34152830 | Strategic Variants of CSP Delivered as SynDNA Vaccines Demonstrate Heterogeneity of Immunogenicity and Protection from Plasmodium Infection in a Murine Model. | Infect Immun | 2021 | https://conductscience.org/library/papers/34152830 | PubMed |
| 31308085 | Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine. | Infect Immun | 2019 | https://conductscience.org/library/papers/31308085 | PubMed |
| 27515826 | Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates. | Malar J | 2016 | https://conductscience.org/library/papers/27515826 | PubMed |
| 24599116 | Fusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilities. | PLoS One | 2014 | https://conductscience.org/library/papers/24599116 | PubMed |
| 23977087 | Computational and experimental validation of B and T-cell epitopes of the in vivo immune response to a novel malarial antigen. | PLoS One | 2013 | https://conductscience.org/library/papers/23977087 | PubMed |
| 22615208 | Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein. | J Immunol | 2012 | https://conductscience.org/library/papers/22615208 | PubMed |
| 20808868 | Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei. | PLoS One | 2010 | https://conductscience.org/library/papers/20808868 | PubMed |
| 20507620 | Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy. | Malar J | 2010 | https://conductscience.org/library/papers/20507620 | PubMed |
| 19915055 | A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria. | J Immunol | 2009 | https://conductscience.org/library/papers/19915055 | PubMed |
| 17239865 | From sequence to antibody: genetic immunisation is suitable to generate antibodies against a rare plant membrane protein, the KAT 1 channel. | FEBS Lett | 2007 | https://conductscience.org/library/papers/17239865 | PubMed |
| 17131235 | Genetic vaccination approaches against malaria based on the circumsporozoite protein. | Wien Klin Wochenschr | 2006 | https://conductscience.org/library/papers/17131235 | PubMed |
| 16622207 | Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein. | Infect Immun | 2006 | https://conductscience.org/library/papers/16622207 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11241272
GET https://conductscience.org/api/papers/v1/11241272/authors